¿Es el PCA3 costoefectivo en Latinoamérica y el Caribe?

Grández-Urbina, José Antonio; Pichardo-Rodríguez, Rafael; Saldaña-Gallo, Jorge

¿Es el PCA3 costoefectivo en Latinoamérica y el Caribe? / Is the PCA3 cost-effective in Latin America and the Caribbean?

Grández-Urbina, José Antonio; Pichardo-Rodríguez, Rafael; Saldaña-Gallo, Jorge.

Grández-Urbina, José Antonio; Clínica de Urología Avanzada Urozen. Lima. PE
Pichardo-Rodríguez, Rafael; Clínica de Urología Avanzada Urozen. Lima. PE
Saldaña-Gallo, Jorge; Clínica de Urología Avanzada Urozen. Lima. PE

Salud pública Méx ; 60(1): 104-105, Jan.-Feb. 2018.

Article in Spanish | LILACS | ID: biblio-903864

Subject(s)

Humans; Male; Prostatic Neoplasms/diagnosis; Adenocarcinoma/diagnosis; Biomarkers, Tumor/blood; Early Detection of Cancer/economics; Neoplasm Proteins/blood; Antigens, Neoplasm/blood; Prostatic Neoplasms/economics; Prostatic Neoplasms/blood; Adenocarcinoma/economics; Adenocarcinoma/blood; Sensitivity and Specificity; Cost-Benefit Analysis; Caribbean Region; Developing Countries/economics; Latin America

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Prostatic Neoplasms / Adenocarcinoma / Biomarkers, Tumor / Early Detection of Cancer / Antigens, Neoplasm / Neoplasm Proteins Type of study: Diagnostic study / Health economic evaluation / Screening study Limits: Humans / Male Language: Spanish Journal: Salud pública Méx Journal subject: Public Health Year: 2018 Type: Article Affiliation country: Peru Institution/Affiliation country: Clínica de Urología Avanzada Urozen/PE

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google